Zenas BioPharma Ratios (2023-2026) | ZBIO

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) 71.25%-1,043.50%-337.78%
EBIT Margin (Quarter) 71.25%-1,112.46%-373.30%
EBITDA Margin (Quarter) 71.25%-1,112.46%-373.30%
Operating Margin (Quarter) 71.25%-1,112.46%-373.30%
Net Margin (Quarter) 71.25%-1,043.50%-335.73%
FCF Margin (Quarter) -772.56%-370.69%
Efficiency
Assets Average (Quarter) 386.70M351.87M313.43M307.55M352.83M565.66M
Asset Utilization Ratio (Quarter) 0.010.040.050.050.03
Leverage & Solvency
Interest Coverage Ratio (Quarter) -3.07-0.16-0.62-19.89-15.72-0.54-0.98-1.12
Debt Ratio (Quarter) 0.230.200.10
Times Interest Earned (Quarter) -3.07-0.16-0.62-19.89-15.72-0.54-0.98-1.12
Valuation
Enterprise Value (Quarter) -72.31M-56.86M-37.24M-184.02M-360.13M-350.77M-430.02M-273.28M-476.92M-343.19M-717.21M
Return Ratios
Return on Sales (Quarter) 0.01%-0.03%-0.10%-0.03%-0.12%-0.13%-0.39%
Return on Capital Employed (Quarter) -49.75%-57.36%-72.68%-78.66%-132.01%-83.86%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%